NexImmune (NASDAQ:NEXI – Get Free Report) and Spyre Therapeutics (NASDAQ:SYRE – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk. Insider and Institutional Ownership 9.9% of NexImmune shares […]
NexImmune, Inc. (NASDAQ:NEXI – Get Free Report) was the recipient of a significant growth in short interest in the month of September. As of September 30th, there was short interest totalling 134,900 shares, a growth of 21.3% from the September 15th total of 111,200 shares. Based on an average daily volume of 83,300 shares, the […]
NexImmune, Inc. (NASDAQ:NEXI – Get Free Report) was the recipient of a significant drop in short interest during the month of July. As of July 15th, there was short interest totalling 286,700 shares, a drop of 19.3% from the June 30th total of 355,400 shares. Approximately 1.8% of the company’s shares are short sold. Based […]
NexImmune, Inc. (NASDAQ:NEXI – Get Rating) shares were up 4.3% during trading on Friday . The stock traded as high as $0.40 and last traded at $0.40. Approximately 38,026 shares traded hands during trading, a decline of 96% from the average daily volume of 1,065,892 shares. The stock had previously closed at $0.38. NexImmune Stock […]